Suven Life Sciences Limited — Important, 13-05-2025: Updates

Suven Life Sciences has announced a board meeting to approve the financial results for the quarter and half-year. The Nomination & Remuneration Committee granted 345,000 stock options at ₹55 each under the SLSL ESOP 2020 scheme, vesting over three years (40% after one year). This highlights the company’s focus on employee retention, with possible equity dilution when options are exercised.